⌘K

Login Start Free

Home/Filings/4/0001470831-25-000412

4//SEC Filing

Doyle Mittie 4

Accession 0001470831-25-000412

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 4:18 PM ET

Size

4.8 KB

Accession

0001470831-25-000412

Insider Transaction Report

Form 4

Period: 2025-12-10

Avalo Therapeutics, Inc.AVTX

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2025-12-10$4.10/sh−1,013$4,153→ 3,622 total

Footnotes (1)

[F1]Includes 3,622 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001918845

Filing Metadata

Form type: 4
Filed: Dec 11, 7:00 PM ET
Accepted: Dec 12, 4:18 PM ET
Size: 4.8 KB

View on SEC.gov